Abstract
With a well-validated aging measure – Phenotypic Age Acceleration (PhenoAgeAccel), this study examined whether and to what extent aging mediates the associations of unhealthy lifestyles with adverse health outcomes. Data were from 405,944 adults (40-69 years) from UK Biobank (UKB) and 9,972 adults (20-84 years) from US National Health and Nutrition Examination Surveys (NHANES). The mediation proportion of PhenoAgeAccel in associations of unhealthy lifestyles with incident cardiovascular disease, incident cancer, and all-cause mortality were 20.0%, 17.8%, and 26.6% (P values <0.001) in UKB, respectively. The mediation proportion of PhenoAgeAccel in associations of lifestyles with cancer mortality, and all-cause mortality were 25.7%, and 35.2% (P values <0.05) in NHANES, respectively. This study demonstrated that accelerated aging partially mediated the associations of lifestyles with adverse health outcomes in UK and US populations. The findings reveal a novel pathway and the potential of geroprotective programs in mitigating health inequality in late-life beyond lifestyle interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a grant from the National Natural Science Foundation of China (82171584), the Fundamental Research Funds for the Central Universities, Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province (2020E10004), and Zhejiang University Global Partnership Fund (188170-11103). This work was also supported by the Career Development Award (K01AG053408) from the National Institute on Aging; Claude D. Pepper Older Americans Independence Center at Yale School of Medicine, funded by the National Institute on Aging (P30AG021342). The funders had no role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UKB was approved by the North West Multi-center Research Ethics Committee, and written informed consent was obtained from all participants.NHANES was approved by the National Center for Health Statistics Research Ethics Review Board, and written informed consent was obtained from all participants
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data and materials are available via UK Biobank at http://www.ukbiobank.ac.uk/. Data from the US National Health and Nutrition Examination Survey (NHANES) are available at the NHANES website: https://www.cdc.gov/nchs/nhanes/index.htm
